The subcutaneous defibrillator: A review of the literature

Journal of the American College of Cardiology

Volumn 63, Issue 15, 2014, Pages 1473-1479

  Aziz, Sally ^a   Leon, Angel R ^b   El Chami, Mikhael F ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

subcutaneous ICD; sudden cardiac death; transvenous ICD

Indexed keywords

BRADYCARDIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DEFIBRILLATION; DEVICE INFECTION; DEVICE SAFETY; ELECTRODE; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEAD MIGRATION; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; CARDIOVERSION; LEAD DISLODGEMENT; PULSE GENERATOR; SKIN DISEASE; SKIN EROSION;

SUBCUTANEOUS ICD; SUDDEN CARDIAC DEATH; TRANSVENOUS ICD;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 84902108642     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.018     Document Type: Review

References (31)

1. D.P. Zipes, and H.J. Wellens Sudden cardiac death Circulation 98 1998 2334 2351
2. R.G. Hauser The subcutaneous implantable cardioverter-defibrillator: should patients want one? J Am Coll Cardiol 61 2013 20 22
3. J.B. van Rees, M.K. de Bie, J. Thijssen, C.J. Borleffs, M.J. Schalij, and L. van Erven Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials J Am Coll Cardiol 58 2011 995 1000
4. T. Kleemann, T. Becker, and K. Doenges et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years Circulation 115 2007 2474 2480
5. J.W. Jarman, K. Lascelles, T. Wong, V. Markides, J.R. Clague, and J. Till Clinical experience of entirely subcutaneous implantable cardioverter- defibrillators in children and adults: cause for caution Eur Heart J 33 2012 1351 1359
6. C.I. Berul, J.K. Triedman, and J. Forbess et al. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report Pacing Clin Electrophysiol 24 2001 1789 1794
7. M. Luedemann, K. Hund, and W. Stertmann et al. Implantable cardioverter defibrillator in a child using a single subcutaneous array lead and an abdominal active can Pacing Clin Electrophysiol 27 2004 117 119
8. N. Madan, J.W. Gaynor, and R. Tanel et al. Single-finger subcutaneous defibrillation lead and "active can": a novel minimally invasive defibrillation configuration for implantable cardioverter-defibrillator implantation in a young child J Thorac Cardiovasc Surg 126 2003 1657 1659
9. P.P. Lupo, G. Pelissero, H. Ali, R. Sanghera, and R. Cappato Development of an entirely subcutaneous implantable cardioverter-defibrillator Prog Cardiovasc Dis 54 2012 493 497
10. G.H. Bardy, W.M. Smith, and M.A. Hood et al. An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
11. L. Dabiri Abkenari, D.A. Theuns, and S.D. Valk et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center Clin Res Cardiol 100 2011 737 744
12. L.R. Olde Nordkamp, L. Dabiri Abkenari, and L.V. Boersma et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort J Am Coll Cardiol 60 2012 1933 1939
13. J.W. Jarman, and D.M. Todd United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn Europace 15 2013 1158 1165
14. R. Weiss, B.P. Knight, and M.R. Gold et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator Circulation 128 2013 944 953
15. J. Kobe, F. Reinke, and C. Meyer et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter- defibrillators: a multicenter case-control study Heart Rhythm 10 2013 29 36
16. A. Aydin, F. Hartel, and M. Schluter et al. Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience Circ Arrhythm Electrophysiol 5 2012 913 919
17. M.S. Wathen, P.J. DeGroot, and M.O. Sweeney et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
18. I. Crozier The subcutaneous defibrillator will replace the transvenous defibrillator J Interv Card Electrophysiol 32 2011 73 77
19. B.B. Lerman, and O.C. Deale Relation between transcardiac and transthoracic current during defibrillation in humans Circ Res 67 1990 1420 1426
20. G.P. Walcott, C.R. Killingsworth, and R.E. Ideker Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction? Resuscitation 59 2003 59 70
21. C. Hasdemir, N. Shah, and A.P. Rao et al. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks J Cardiovasc Electrophysiol 13 2002 144 150
22. C.P. Rowley, and M.R. Gold Subcutaneous implantable cardioverter defibrillator Circ Arrhythm Electrophysiol 5 2012 587 593
23. J.E. Poole, G.W. Johnson, and A.S. Hellkamp et al. Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
24. A.J. Moss, C. Schuger, and C.A. Beck et al. Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
25. M.R. Gold, D.A. Theuns, and B.P. Knight et al. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study J Cardiovasc Electrophysiol 23 2012 359 366
26. J.P. Daubert, W. Zareba, and D.S. Cannom et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
27. M. Burke, B. Knight, and M.R. Gold et al. Safety and efficacy of a subcutaneous implantable-defibrillator (abstr) Heart Rhythm 9 2012 1579 1580
28. R.E. Knops, L.R. Olde Nordkamp, J.R. de Groot, and A.A. Wilde Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator Heart Rhythm 10 2013 1240 1243
29. H.C. Kamphuis, J.R. de Leeuw, R. Derksen, R.N. Hauer, and J.A. Winnubst Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study Europace 5 2003 381 389
30. R.P. Ricci, L. Morichelli, and A. D'Onofrio et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry Europace 15 2013 970 977
31. L. Guedon-Moreau, D. Lacroix, and N. Sadoul et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial Eur Heart J 34 2013 605 614